Clinical trial
RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV…
NCT00002462 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Active, not recruiting
Key facts
| NCT number | NCT00002462 |
|---|---|
| Title | RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease |
| Official title | Phase III Randomized Trial of Adjuvant Involved-Field Radiotherapy vs No Adjuvant Therapy Following Remission Induction With MOPP/ABV Hybrid Chemotherapy in Patients With Stage III/IV Hodgkin's Disease |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Active, not recruiting |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug, Radiation |
| Interventions | bleomycin sulfate, doxorubicin hydrochloride, mechlorethamine hydrochloride, prednisone, procarbazine hydrochloride, vinblastine sulfate, vincristine sulfate, low-LET cobalt-60 gamma ray therapy, low-LET photon therapy, radiation therapy |
| Enrollment | 615 |
| Start date | Sep 1, 1989 |
| Primary completion | May 1, 2000 |
| First posted | Jul 26, 2004 |
| Last update posted | Aug 5, 2025 |
| Countries | Belgium, Egypt, France, Germany, Italy, Netherlands, Poland, Portugal, Slovenia |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: